CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation Study
Titel:
CD206-Targeted Liposomal Myelin Basic Protein Peptides in Patients with Multiple Sclerosis Resistant to First-Line Disease-Modifying Therapies: A First-in-Human, Proof-of-Concept Dose-Escalation Study
Auteur:
Belogurov, Alexey Zakharov, Konstantin Lomakin, Yakov Surkov, Kirill Avtushenko, Sergey Kruglyakov, Peter Smirnov, Ivan Makshakov, Gleb Lockshin, Curtis Gregoriadis, Gregory Genkin, Dmitry Gabibov, Alexander Evdoshenko, Evgeniy